Glenmark Pharma is recalling close to 15 lakh bottles of a generic medication used in the treatment of ADHD in the US market, the US health regulator said. The company is recalling the lot due to “CGMP deviations”, the regulator USFDA said. The recall is due to “presence of N-Nitroso Atomoxetine impurity above the FDA recommended limit,” it added. agencies
Glenmark recalls ADHD medicine bottles in US
Date:
More like thisRelated
‘RCB fans are indebted’: Tejasvi Surya’s sarcastic salvo at Siddaramaiah, Shivakumar after Bengaluru stampede; Virat Kohli gets a mention | India News
NEW DELHI: Bharatiya Janata Party MP Tejasvi...
Germany vows continued support of Israel as FM visits Berlin
German foreign minister Johann Wadephul (Image credit: AP)...
Crypto trading in India: Could hamper financial stability, says RBI gov; no new Bill yet
The Reserve Bank of India once again...
Shraddha Kapoor’s family moment: Actress enjoys quality time with aunt Tejaswini Kolhapure and cousins – It’s all about ‘Gupshup khana aur khandan’ |
Shraddha Kapoor, or as the Bollywood buffs...